Weekly CEO Sells Highlight: WLL, PDE, HUM, SGEN

Author's Avatar
Mar 20, 2011
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: WHITING PETROLEUM Corp, PRIDE INTERNATIONAL INC, HUMANA INC, and Seattle Genetics Inc.

WHITING PETROLEUM Corp. (WLL, Financial): Chairman and CEO James J Volker sold 215,900 Shares

Chairman and CEO of WHITING PETROLEUM Corp. (WLL) James J Volker sold 215,900 shares on 03/11/2011 at an average price of $63.03. WHITING PETROLEUM CORPORATION, a Delaware corporation, is an independent oil and gas company that acquires, exploits, develops and explores for crude oil, natural gas and natural gas liquids primarily in the Permian Basin, Rocky Mountains, Mid-Continent, Gulf Coast and Michigan regions of the United States. Whiting Petroleum Corp. has a market cap of $7.78 billion; its shares were traded at around $65.9 with a P/E ratio of 24.3 and P/S ratio of 5.2. Whiting Petroleum Corp. had an annual average earnings growth of 4.8% over the past 5 years.

WHITING PETROLEUM Corp reported their 2010 quarter results. The Company reported net income of $65.9 million and revenues of $413.5 million.

Chairman and CEO James J Volker sold 215,900 shares of WLL stock on 03/11/2011 at the average price of 63.03.Vice President and CFO Michael J Stevens sold 13,412 shares of WLL stock on 11/01/2010 at the average price of 50.04. Director Philip Edward Doty bought 1,000 shares of WLL stock on 11/01/2010 at the average price of 50.29. Vice President John Douglas Lang sold 8,728 shares of WLL stock in March. Vice President Rick A Mr. Ross sold 7,368 shares of WLL stock on 03/02/2011 at the average price of 67.66.

PRIDE INTERNATIONAL INC. (PDE, Financial): President and CEO Louis Raspino sold 207,484 Shares

President and CEO of PRIDE INTERNATIONAL INC. (PDE) Louis Raspino sold 207,484 shares on 03/15/2011 at an average price of $41.99. Pride is a international provider of contract drilling and relatedservices, operating both offshore and on land. Pride International Inc. has a market cap of $7.38 billion; its shares were traded at around $41.69 with a P/E ratio of 28 and P/S ratio of 5.1. Pride International Inc. had an annual average earnings growth of 5.4% over the past 10 years.

PRIDE INTERNATIONAL INC. reported 2010 fourth quarter results. The Company reported revenues of $270.9 million and net income of $52.1 million.

President and CEO Louis Raspino sold 37,457 shares of PDE stock in January and March.Director Kenneth Michael Burke sold 15,500 shares of PDE stock in March. SrVP & Chief Admin Officer W Gregory Looser, SrVP - Human Resources & Admin Lonnie D Bane, and & Chief Accounting Officer Leonard Travis sold 245,179 shares of PDE stock in March.

HUMANA INC. (HUM, Financial): Chairman of the Board & CEO Michael B Mccallister sold 200,000 Shares

Chairman of the Board & CEO of HUMANA INC. (HUM) Michael B Mccallister sold 200,000 shares on 03/15/2011 at an average price of $63. Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. Humana Inc. has a market cap of $10.95 billion; its shares were traded at around $64.91 with a P/E ratio of 9.3 and P/S ratio of 0.3. Humana Inc. had an annual average earnings growth of 23.5% over the past 10 years. GuruFocus rated Humana Inc. the business predictability rank of 3.5-star.

HUMANA INC. reported their 2010 fourth quarter results. The Company reported revenues of $8.35 billion and net income of $107.3 million.

Chairman of the Board & CEO Michael B Mccallister sold 200,000 shares of HUM stock on 03/15/2011. Sr VP & Chief Serv. & Info. Of Bruce J Goodman, Sr. VP and General Counsel M Todoroff Christopher, and Sr VP & Chief Human Res. Off Bonnie C Hathcock sold 128,018 shares of HUM in March.COO James E Murray sold 336,000 shares of HUM stock on 03/03/2011.

Seattle Genetics Inc. (SGEN, Financial): President and CEO Clay B Siegall sold 200,000 Shares

President and CEO of Seattle Genetics Inc. (SGEN) Clay B Siegall sold 200,000 shares on 03/17/2011 at an average price of $14.09. Seatlle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Seattle Genetics Inc. has a market cap of $1.62 billion; its shares were traded at around $14.28 with and P/S ratio of 15.2. Seattle Genetics Inc. had an annual average earnings growth of 2.2% over the past 10 years.

Seattle Genetics Inc. reported their fourth quarter 2010 results. The Company reported revenues of $8.1 million and net loss of $34.5 million.

President and CEO Clay B Siegall sold 200,000 shares of SGEN stock on 03/17/2011. EVP, Process Sciences Morris Rosenberg sold 75,000 shares of SGEN stock in November and December.

For the complete list of stocks that bought by their CEOs, go to: CEO Buys.